We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for MR Composition Service.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

MR Composition Service - List of Manufacturers, Suppliers, Companies and Products

MR Composition Service Product List

1～2 item / All 2 items

Displayed results
Custom mRNA synthesis service

Custom mRNA synthesis service

Would you like to obtain high-quality mRNA in milligram quantities to accelerate research and development and improve reliability?

Our company offers custom mRNA synthesis, providing a complete mRNA production process from gene synthesis to purification. By simply submitting the sequence information of the desired messenger RNA (mRNA), you can receive purified and lyophilized mRNA transcripts. All of these processes are carried out in-house. Please feel free to contact us with any requests. 【Our Strengths】 ■ Short turnaround time ■ High quality ■ Ph.D.-level customer support ■ Efficient project management ■ High flexibility to meet various requests *For more details, please download the PDF or feel free to contact us.

  • DNA/RNA synthesis

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Custom mRNA synthesis service - LNP compatible, GMP compliant

Custom mRNA synthesis service - LNP compatible, GMP compliant

Proposing optimal arrangement, encapsulation into LNP, and GMP manufacturing support.

Features - Manufacturing of mRNA/LNP for research and pharmaceutical applications - Encapsulation of mRNA using lipid nanoparticles (LNP) - mRNA with high expression efficiency of proteins - High-quality mRNA with low impurities (endotoxins, DNA, dsRNA, enzymes) Burnal Corporation has facilities capable of manufacturing mRNA and lipid nanoparticles (LNP) at GMP grade, allowing for the production of both research-grade and pharmaceutical-grade mRNA/LNP. By 2025, a new manufacturing facility will be operational, increasing the available quantity of mRNA from approximately 10 grams to around 100 grams, enabling supply at the level of approved drugs. This consistent provision of raw materials from early research to pharmaceuticals allows for uninterrupted development speed.

  • DNA/RNA synthesis

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.